High expression of Eg5 quantified by IHC was also found to predict brain metastasis following primary tumour resection in LUAD patients and to predict response to platinum chemotherapy combined with anti-mitotic agents in a retrospective NSCLC study [64,65]. The gene discussed is KIF11; the disease is neoplasm.